Tuesday, 02 January 2024 12:17 GMT

PLT Wants Attendees To 'Feel The Science' With Disruptive Beverage-Friendly Ingredients At IFT First 2025


(MENAFN- PR Newswire) According to Steve Fink, Vice President of Marketing at PLT Health Solutions, consumer experience is becoming a critical factor for product success-especially in the beverage sector. "Efficacy will always be the foundation when it comes to science-backed ingredients," said Fink. But today's consumers expect more than just results-they're looking for products that align with their values and deliver a complete experience. That includes clean sourcing, traceability, and certifications-but also faster effects, enjoyable delivery formats, and standout packaging. In many ways, the experience of a product has become just as important as the science behind it. At IFT, we want the food and beverage industry to visit our booth, sample our ingredients and 'feel the science,' he added.

Highlighting Four Hot Health & Wellness Categories

For several years, functional beverages have been one of the fastest growing segments of the natural products industry. At IFT, PLT will be featuring beverage-friendly ingredients that add more function than traditional ingredients like vitamins, protein and minerals.

Energy
PLT offers both stimulant and non-stim energy ingredients with its zumXR® Extended Release Caffeine and Zynamite® – via the new Zynamite S format. Both are subjects of recently completed clinical trials.

Cognitive
Cognitive ingredients presented at IFT First 2025 include Rhodiolife® Rhodolia rosea, a true adaptogen offering reduced mental and physical stress and emotional balance. Also featured will be Zembrin Sceletium tortuosum that has extensive clinical work showing reduced stress and enhanced mood in less than 2 hours from ingestion.

Sports/Active Nutrition
As part of its Sports/Active Nutrition portfolio, beverage friendly ingredients include MegaNatual-BP® grape seed extract and and cellflo6 for enhanced blood flow and improved physical performance. cellflo6 has found success in experiential sports nutrition formulations.

Weight Management
PLT's award-winning weight management ingredient portfolio will feature beverage friendly Slendacor® Weight Management Complex and Supresa® Crave Control. Slendacor has been the subject of multiple clinical studies that have demonstrated fast-acting weight loss, non-stimulant calorie burning and body shaping. Supresa has been clinically demonstrated to help people resist the urge to snack.

According to Fink, with consumers increasingly turning to convenient delivery systems, the company has undertaken an across-the-board campaign to create or modify its ingredients to make them formulation-friendly. "For a variety of reasons, beverages present a range of challenges when it comes to consumer sensory and experience. This is especially true when it comes to plant-based and botanical ingredients" he said. "In approaching this development work, we've focused on things beverage producers want: uniform particle size and density, good water dispersibility/solubility, neutral taste and color and stability. At the same time, our beverage-friendly ingredients maintain features that every product developer wants: they are fast-acting to the point of being experiential, they are low dose and maybe most importantly, they are backed by quality clinical science," he added.

The PLT booth will be #S1839.

For more information or to arrange a meeting at IFT, visit .

Media Contact:
Mark Falconer
Sciencewerks, LLC
E-mail: [email protected]
Voice: 407-412-9705

Company Contact:
Steve Fink, Vice President, Marketing
PLT Health Solutions, Inc.
E-mail: [email protected]

SOURCE PLT Health Solutions

MENAFN11062025003732001241ID1109660896


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search